Featured Publications
Assessing pain in persons with opioid use disorder: Approaches, techniques and special considerations
Nunes J, Costa G, Weleff J, Rogan M, Compton P, De Aquino J. Assessing pain in persons with opioid use disorder: Approaches, techniques and special considerations. British Journal Of Clinical Pharmacology 2024 PMID: 38556851, DOI: 10.1111/bcp.16055.Peer-Reviewed Original ResearchOpioid use disorderAssess painPain assessmentPain experienceConcomitant chronic painChronic opioid therapyQuantitative sensory testingVisual analogue scalePain assessment methodsPain assessment toolsComplex psychosocial backgroundImprove pain assessmentOpioid therapyOpioid usePain responseChronic painAnalogue scaleTraditional self-report methodsPainRisk factorsUse disorderOpioidNarrative reviewSelf-report methodsMultidisciplinary team
2024
Disentangling the effects of racism-related stress on opioid use disorder and chronic pain outcomes
Nunes J, Jegede O, De Aquino J. Disentangling the effects of racism-related stress on opioid use disorder and chronic pain outcomes. The American Journal Of Drug And Alcohol Abuse 2024, 50: 455-461. PMID: 39018662, DOI: 10.1080/00952990.2024.2369866.Peer-Reviewed Original ResearchOpioid use disorderUse disorderRacism-related stressChronic pain outcomesOpioid overdose mortality ratesOverdose mortality ratesHealthcare disparitiesBiopsychosocial burdenPain outcomesPrescribed opioidsUndertreated painChronic painPain managementOpioid mortalityPerpetuate stigmaTreat painPain experienceOpioidPainRisk factorsMinoritized populationsMinoritized peopleMortality rateDisparitiesAddiction treatment
2022
Cocaine Use Disorder (CUD): Current Clinical Perspectives
Schwartz EKC, Wolkowicz NR, De Aquino JP, MacLean RR, Sofuoglu M. Cocaine Use Disorder (CUD): Current Clinical Perspectives. Substance Abuse And Rehabilitation 2022, 13: 25-46. PMID: 36093428, PMCID: PMC9451050, DOI: 10.2147/sar.s337338.Peer-Reviewed Original ResearchCocaine use disorderCo-occurring disordersUse disordersCommon co-occurring disordersCurrent clinical perspectivesSubstance use disordersCognitive behavioral therapyMedication treatmentPharmacological treatmentRisk factorsCurrent treatmentDevastating disorderLarger sample sizeTreatment planChronic effectsCocaine useBehavioral treatmentClinical perspectiveBehavioral interventionsDisordersTreatmentFuture studiesMost individualsIndividualsSample size
2020
Cannabinoids
De Aquino J, Arnaout B. Cannabinoids. 2020, 153-167. DOI: 10.1007/978-3-030-33404-8_10.Peer-Reviewed Original ResearchCannabis use disorderUse of cannabinoidsPotential pharmacokinetic interactionsEffects of cannabinoidsDose-dependent effectPharmacokinetic interactionsPsychotropic medicationsRisk factorsPsychosocial treatmentsPsychiatric disordersUse disordersAddiction specialistsHealthcare providersPsychomotor functioningCannabinoidsSynthetic cannabinoidsDisordersMedicinal useMedicationsPatientsProgression
2017
An Update on the Epidemiology of Major Depressive Disorder Across Cultures
De Aquino J, Londono A, Carvalho A. An Update on the Epidemiology of Major Depressive Disorder Across Cultures. 2017, 309-315. DOI: 10.1007/978-981-10-6580-4_25.Peer-Reviewed Original ResearchPrevalence of major depressive disorderMajor depressive disorderAssociation of Major Depressive DisorderIdentification of environmental risk factorsPrevalent public health issueTargeted prevention strategiesCross-sectional epidemiological dataMiddle-income countriesHigh-income countriesPublic health issueInternational epidemiological studiesEnvironmental risk factorsIdentification of vulnerable individualsDepressive disorderPublic health concernEpidemiological researchEmployment statusPoor functional outcomeHealth issuesPrevention strategiesElevated riskEpidemiological studiesHealth concernRisk factorsEpidemiological data